HIV/HCV coinfection at an university hospital in Recife, Brazil;Co-infecção por HIV/HCV em hospital universitário de Recife, Brasil

Revista de Saude Publica

Volumn 43, Issue 1, 2009, Pages 133-139

  de Carvalho, Flávia Helena Pontes ^a   Duarte Coêlho, Maria Rosângela Cunha ^a   de Aguiar Santos Vilella, Tatiana ^a   Almeida Silva, Jéfferson Luis ^a   de Lacerda Melo, Heloísa Ramos ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Cross sectional studies; Hepatitis C, epidemiology; HIV infections, epidemiology; Risk factors; Seroepidemiologic studies

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD; BLOOD TRANSFUSION; BRAZIL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEX RATIO; STATISTICS; UNIVERSITY HOSPITAL; VIROLOGY;

ADULT; AGE DISTRIBUTION; BLOOD TRANSFUSION; BRAZIL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SEX DISTRIBUTION;

EID: 67649403869     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102009000100017     Document Type: Article

References (28)

1. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 2004;5(3):174-9. DOI: 10.1111/j.1468-1293.2004.00207.x
2. Braga EL, Lyra AC, Ney-Oliveira F, Nascimento L, Silva A, Brites C, et al. Clinical and epidemiological features of patients with chronic hepatitis c co-infected with HIV. Braz J Iinfect Dis. 2006;10(1):17-21. DOI: 10.1590/S1413-86702006000100004
3. Bräu N, Bini EJ, Shahidi A, Aytaman A, Xiao P, Stancic S, et al. Prevalence of hepatitis c and coinfection with HIV among United States Veterans in the New York City metropolitan area. Am J Gastroenterol. 2002;97(8):2071-8.
4. Campiotto S, Pinho JRR, Carrilho FJ, Da Silva LC, Souto FJD, Spinelli V, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res. 2005;38(1):41-9. DOI: 10.1590/S0100-879X2005000100007
5. Carneiro MA, Teles SA, Dias MA, Ferreira RC, Naghettine AV, Silva SA, et al. Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Mem Inst Oswaldo Cruz. 2005;100(4):345-9. DOI: 10.1590/S0074-02762005000400002
6. Caseiro MM, Braz IAN, Costa SOP, Ebner W. Prevalência de marcador para vírus da hepatite c (anti-HCV) em pacientes infectados pelo HIV-1, em 6 municípios da baixada santista [resumo]. Rev Soc Bras Med Trop. 2004;37:112. [Apresentado no 40. Congresso da Sociedade Brasileira de Medicina Tropical; 2004; Aracaju, BR]
7. Corvino MS, Henriques RMS, Grotto MT, Pardini MIMC. Co-Infecção HIV/HCV em pacientes de Botucatu e região. Rev Bras Epidemiol. 2007;10(4):537-43. DOI: 10.1590/S1415-790X2007000400012
8. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in hemophiliac men and boys in UK given blood products contaminated with hepatitis C. Lancet. 1997;350(9089):1425-31. DOI: 10.1016/S0140-6736(97)05413-5
9. Ferraz GGS, Menezes JA, Gazineo JL, Passoni LFC, Lessa MPM, Pinto PTA, et al. Prevalência de infecção pelo vírus B e C da hepatite em pacientes com infecção pelo vírus da imunodeficiência humana. Rev Med HSE. 2002;36:6-11.
10. Garson, JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, et al. Detection of hepatitis C viral sequences in blood donation by "nested" polymerase chain reaction and prediction of infectivity. Lancet. 1990;335(8703):1419-22. DOI: 10.1016/0140-6736(90)91446-H
11. Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, et al. Demonstration of viraemia patterns in hemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet. 1990;336(8722):1022-25. DOI: 10.1016/0140-6736(90)92487-3
12. Kwok S, Higushi R. Avoiding false positives with PCR. Nature. 1989;339(6221):237-8. DOI: 10.1038/339237a0
13. Mendes-Corrêa MCJ, Barone AA, Guastini C. Hepatitis C virus Seroprevalence and risk factors among patients with HIV infection. Rev Inst Med Trop Sao Paulo. 2001;43(1):15-9. DOI: 10.1590/S0036-46652001000100003
14. Monteiro MRCC, Nascimento MMP, Passos ADC, Figueiredo JFC. Hepatite C: prevalência e fatores de risco entre portadores de VIH/SIDA em Belém, Pará, na Amazônia brasileira. Rev Soc Bras Med Trop. 2004;37(2):40-6.
15. Motta TQR, Tose S, Boni M, Gonçalves FL, Fausto MLC, Pereira L. Prevalência e fatores de risco para a infecção com o vírus da hepatite C em pacientes infectados com o HIV em Vitória [resumo]. Rev Soc Bras Med Trop. 2004;37(Supp 1):104. [Apresentado no 40. Congresso da Sociedade Brasileira de Medicina Tropical; 2004; Aracaju, BR]. DOI: 10.1590/S0037-86822004000300018
16. Pavan MH, Aoki FH, Monteiro DT, Goncales NS, Escanhoela CA, Goncales Júnior FL. Viral hepatitis in patients infected with human immunodeficiency virus. Braz J Infect Dis. 2003;7(4):253-61. DOI: 10.1590/S1413-86702003000400005
17. Perrilo RP. The role of liver biopsy in hepatitis C. Hepatology. 1997;26(Supp 3):S57-61. DOI: 10.1002/hep.510260710
18. Rockstroh JK, Mudar M, Lichterfeld M, Nischalke HD, Klausen G, Gölz J, et al. Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients. AIDS. 2002;16(15):2083-5. DOI: 10.1097/00002030-200210180-00016
19. Rodriguez-Rosado R, Garcia-Samaniego J, Soriano V. Hepatotoxicity after introduction of highly active antiretroviral therapy. AIDS 1999;12(10):1256. DOI: 10.1097/00002030-199810000-00025
20. Rubio M, Rubio C, Nogués A, Manonelles A. Hepatitis C virus genotypes. Study of 302 patients coinfected by the human immunodeficiency virus. Med Clin (Barc). 2001;116(17):650-1.
21. Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, et al. Care of patients with chronic hepatitis C and HIV coinfection: recommendations from the HIV-HCV International Panel. AIDS. 2002;16(6):813-28. DOI: 10.1097/00002030-200204120-00001
22. Segurado AC, Braga P, Etzel A, Cardoso MR. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS. 2004;18(3):135-43. DOI: 10.1089/108729104322994829
23. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34(6):831-7. DOI: 10.1086/339042
24. Szwarcwald CL, Bastos FI, de Castilho EA. The dynamics of the AIDS epidemic in Brazil: a space-time analysis in the period 1987-1995. Braz J Infect Dis. 1998;2(4):175-86.
25. Szwarcwald CL, Bastos FI, Esteves MAP, Andrade CLT. A disseminação da epidemia da AIDS no Brasil, no período de 1987-1996: Uma análise espacial. Cad Saude Publica. 2000;16(Supp 1):S07-19.
26. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatol. 2002;36(5 Supp 1):S201-9. DOI: 10.1053/jhep.2002.36380
27. Tovo CV, Santos DE, Mattos AZ, Almeida PR, Mattos AA, Santos BR. Prevalência ambulatorial em um hospital geral de marcadores para hepatites B e C em pacientes com infecção pelo vírus da imunodeficiência humana. Arq Gastroenterol. 2006;43(2):73-6. DOI: 10.1590/S0004-28032006000200002
28. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000;13(2):223-35. DOI: 10.1128/CMR.13.2.223-235.2000